Subject(s)
Astrocytes/metabolism , Lipid Metabolism , Neuroglia/metabolism , Animals , Astrocytes/analysis , Brain/cytology , Brain Chemistry , Cells, Cultured , Cricetinae , Glioma/metabolism , Glucose/metabolism , Lipids/analysis , Nerve Tissue Proteins/analysis , Neurons/metabolism , Phospholipids/analysis , Triglycerides/analysisABSTRACT
Platelet monoamine oxidase (MAO) activity was significantly lower than control values in a subgroup of 16 schizophrenic patients (most of whom were paranoid) characterized by the presence of auditory hallucinations and delusions. Platelet MAO activity was not reduced in 16 other schizophrenic patients without auditory hallucinations. This finding suggests that reduced platelet MAO activity is not found in all schizophrenic patients but tends to occur in a clinically identifiable subgroup.
Subject(s)
Blood Platelets/enzymology , Monoamine Oxidase/metabolism , Schizophrenia/enzymology , Auditory Perception , Delusions , Hallucinations , Humans , Schizophrenia, Paranoid/enzymologySubject(s)
Pineal Gland/metabolism , Animals , Chick Embryo , Culture Media , Ducks , Organ Culture Techniques/methods , RatsABSTRACT
Major increases in the serotonin concentrations of rat pineal organs were produced by administering Catron, a monoamine oxidase inhibitor, prior to autopsy, or by preincubating the glands with serotonin (3X10-4M). These increases had no effect on pineal uptake of H3-tryptophan, the amino acid precursor for serotonin. These observations provide further evidence that the control of serotonin synthesis involves an important "open-loop" component.
Subject(s)
Pineal Gland/metabolism , Serotonin/metabolism , Tryptophan/metabolism , Animals , Hydrazines/pharmacology , In Vitro Techniques , Pineal Gland/drug effects , RatsSubject(s)
Phospholipids/metabolism , Pineal Gland/metabolism , Receptors, Adrenergic/drug effects , Animals , Diglycerides/biosynthesis , Glycerophosphates/biosynthesis , Male , Norepinephrine/pharmacology , Phenoxybenzamine/pharmacology , Phentolamine/pharmacology , Phenylephrine/pharmacology , Phosphatidic Acids/biosynthesis , Phosphatidylcholines/biosynthesis , Phosphatidylinositols/biosynthesis , Phosphorus Radioisotopes , Pineal Gland/drug effects , Propranolol/pharmacology , Rats , Stimulation, ChemicalSubject(s)
Astrocytoma/enzymology , Brain Neoplasms/enzymology , Brain/enzymology , Neuroblastoma/enzymology , Phosphoric Diester Hydrolases/analysis , Animals , Cattle , Clone Cells , Cyclic AMP , Dialysis , Drug Stability , Electrophoresis, Polyacrylamide Gel , Enzyme Activation/drug effects , Kinetics , Male , Mice , Neoplasms, Experimental/enzymology , Neuroglia/enzymology , Phosphodiesterase Inhibitors , Rats , Serum Albumin, Bovine , Theophylline/pharmacology , Trifluoperazine/pharmacologySubject(s)
Interpersonal Relations , Psychotherapy , Schizophrenia/therapy , Social Isolation , Adolescent , Adult , Attitude , Cognition , Defense Mechanisms , Emotions , Female , Humans , Male , Narcissism , Physician-Patient Relations , Schizophrenic Psychology , Social AdjustmentSubject(s)
Astrocytoma/metabolism , Brain Neoplasms/metabolism , Cell Transformation, Neoplastic , Lipid Metabolism , Neuroglia/metabolism , Nucleic Acids/metabolism , Polyomavirus , Proteins/metabolism , Animals , Astrocytoma/etiology , Brain/metabolism , Cell Line , Cells, Cultured , Ceramides/metabolism , Cholesterol/metabolism , Clone Cells , Cricetinae , DNA/metabolism , Disease Models, Animal , Gangliosides/metabolism , Lipoproteins/metabolism , Neoplasms, Experimental , Oncogenic Viruses , Phospholipids/metabolism , RNA/metabolismSubject(s)
Adrenergic beta-Antagonists/pharmacology , Catecholamines/pharmacology , Phosphates/metabolism , Phosphatidylinositols/biosynthesis , Phospholipids/biosynthesis , Pineal Gland/metabolism , Animals , Autoradiography , Butyrates/pharmacology , Chromatography, Thin Layer , Cyclic AMP/pharmacology , Female , Kinetics , Norepinephrine/pharmacology , Organ Culture Techniques , Phenethylamines/pharmacology , Phenoxybenzamine/pharmacology , Phosphatidylcholines/biosynthesis , Phosphatidylethanolamines/biosynthesis , Phospholipids/isolation & purification , Phosphorus Isotopes , Pineal Gland/drug effects , Rats , Receptors, Adrenergic , Structure-Activity RelationshipABSTRACT
The soluble supernatant fraction of homogenates of cloned rat astrocytoma cells (linle C-2A) was subjected to polyacrylamide gel electrophoresis. Two peaks of adenosine 3',5'-monophosphate phosphodiesterase activity were found, corresponding to peaks I and IV of a similarly prepared homogenate of rat brain. Incubating cells with norepinephrine (0.3 mullimolar) caused about a threefold increase in the activity of peak IV but no change in peak I. This increase was completely inhibited by prior inclubation with propranolol (0.1 millimnolar), a beta-adrenergic blocking agent, or with cyclohexamnine (40 micromolar). a protein synthesis inhibitor. Induction of a specific phosphodiesterase form by norepinephrine sitggests another feedback control mechanism whereby an organism can prevent the effects of excessive sympathetic activity.